|
 |
|
|||||||
|
|||||||||
Diabetes 51:S434-S442, 2002
© 2002 by the American Diabetes Association, Inc.
Section 5: Beta-Cell Stimulus-Secretion Coupling: Hormonal and Pharmacological Modulators |
The Multiple Actions of GLP-1 on the Process of Glucose-Stimulated Insulin Secretion
1 Departments of Medicine and Physiology, University of Toronto, Toronto, Ontario, Canada
2 Department of Pharmacology, University of Alberta, Edmonton, Alberta, Canada
The physiological effects of glucagon-like peptide-1 (GLP-1) are of immense interest because of the potential clinical relevance of this peptide. Produced in intestinal L-cells through posttranslational processing of the proglucagon gene, GLP-1 is released from the gut in response to nutrient ingestion. Peripherally, GLP-1 is known to affect gut motility, inhibit gastric acid secretion, and inhibit glucagon secretion. In the central nervous system, GLP-1 induces satiety, leading to reduced weight gain. In the pancreas, GLP-1 is now known to induce expansion of insulin-secreting ß-cell mass, in addition to its most well-characterized effect: the augmentation of glucose-stimulated insulin secretion. GLP-1 is believed to enhance insulin secretion through mechanisms involving the regulation of ion channels (including ATP-sensitive K+ channels, voltage-dependent Ca2+ channels, voltage-dependent K+ channels, and nonselective cation channels) and by the regulation of intracellular energy homeostasis and exocytosis. The present article will focus principally on the mechanisms proposed to underlie the glucose dependence of GLP-1’s insulinotropic effect.
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Edfalk, P. Steneberg, and H. Edlund Gpr40 Is Expressed in Enteroendocrine Cells and Mediates Free Fatty Acid Stimulation of Incretin Secretion Diabetes, September 1, 2008; 57(9): 2280 - 2287. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Burcelin, P. D. Cani, and C. Knauf Glucagon-Like Peptide-1 and Energy Homeostasis J. Nutr., November 1, 2007; 137(11): 2534S - 2538S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Muscelli, A. Mari, A. Natali, B. D. Astiarraga, S. Camastra, S. Frascerra, J. J. Holst, and E. Ferrannini Impact of incretin hormones on beta-cell function in subjects with normal or impaired glucose tolerance Am J Physiol Endocrinol Metab, December 1, 2006; 291(6): E1144 - E1150. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Suzuki, H. Zhang, N. Saito, I. Kojima, T. Urano, and H. Mogami Glucagon-like Peptide 1 Activates Protein Kinase C through Ca2+-dependent Activation of Phospholipase C in Insulin-secreting Cells J. Biol. Chem., September 29, 2006; 281(39): 28499 - 28507. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T S McQuaid, M C Saleh, J W Joseph, A Gyulkhandanyan, J E Manning-Fox, J D MacLellan, M B Wheeler, and C B Chan cAMP-mediated signaling normalizes glucose-stimulated insulin secretion in uncoupling protein-2 overexpressing {beta}-cells. J. Endocrinol., September 1, 2006; 190(3): 669 - 680. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. H McClenaghan, P. R Flatt, and A. J Ball Actions of glucagon-like peptide-1 on KATP channel-dependent and -independent effects of glucose, sulphonylureas and nateglinide. J. Endocrinol., September 1, 2006; 190(3): 889 - 896. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-G. Ostenson, H. Gaisano, L. Sheu, A. Tibell, and T. Bartfai Impaired Gene and Protein Expression of Exocytotic Soluble N-Ethylmaleimide Attachment Protein Receptor Complex Proteins in Pancreatic Islets of Type 2 Diabetic Patients Diabetes, February 1, 2006; 55(2): 435 - 440. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Stanley, K. Wynne, B. McGowan, and S. Bloom Hormonal Regulation of Food Intake Physiol Rev, October 1, 2005; 85(4): 1131 - 1158. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Seino and T. Shibasaki PKA-Dependent and PKA-Independent Pathways for cAMP-Regulated Exocytosis Physiol Rev, October 1, 2005; 85(4): 1303 - 1342. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-J. Kim, W. S. Choi, J. S. M. Han, G. Warnock, D. Fedida, and C. H. S. McIntosh A Novel Mechanism for the Suppression of a Voltage-gated Potassium Channel by Glucose-dependent Insulinotropic Polypeptide: PROTEIN KINASE A-DEPENDENT ENDOCYTOSIS J. Biol. Chem., August 5, 2005; 280(31): 28692 - 28700. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Thams, M. R Anwar, and K. Capito Glucose triggers protein kinase A-dependent insulin secretion in mouse pancreatic islets through activation of the K+ATP channel-dependent pathway Eur. J. Endocrinol., April 1, 2005; 152(4): 671 - 677. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Wynne, S. Stanley, B. McGowan, and S. Bloom Appetite control J. Endocrinol., February 1, 2005; 184(2): 291 - 318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. V. Rocheleau, G. M. Walker, W. S. Head, O. P. McGuinness, and D. W. Piston Microfluidic glucose stimulation reveals limited coordination of intracellular Ca2+ activity oscillations in pancreatic islets PNAS, August 31, 2004; 101(35): 12899 - 12903. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. D'Alessio and T. P. Vahl Glucagon-like peptide 1: evolution of an incretin into a treatment for diabetes Am J Physiol Endocrinol Metab, June 1, 2004; 286(6): E882 - E890. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |